Active matrix metalloproteases are expressed early on and are high during the Barrett’s esophagus malignancy sequence

References

• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893–917.
   PubMed Web of Science ®Google Scholar
• Botterweck AA, Schouten LJ, Volovics A, Dorant E, van den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000;29:645–54.
   PubMed Web of Science ®Google Scholar
• Pera M, Manterola C, Vidal O, Grande L. Epidemiology of esophageal adenocarcinoma. J Surg Oncol 2005;92:151–9.
   PubMed Web of Science ®Google Scholar
• Desai TK, Krishnan K, Samala N, Singh J, Cluley J, Perla S, et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett’s oesophagus: a meta-analysis. Gut 2011;61:970–6.
   PubMed Web of Science ®Google Scholar
• Hvid-Jensen F, Pedersen L, Drewes AM, Sorensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett’s esophagus. N Engl J Med 2011;365:1375–83.
   PubMed Web of Science ®Google Scholar
• Sikkema M, de Jonge PJ, Steyerberg EW, Kuipers EJ. Risk of esophageal adenocarcinoma and mortality in patients with Barrett’s esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2010;8:235–44.
   PubMed Web of Science ®Google Scholar
• de Jonge PJ, van Blankenstein M, Looman CW, Casparie MK, Meijer GA, Kuipers EJ. Risk of malignant progression in patients with Barrett’s oesophagus: a Dutch nationwide cohort study. Gut 2010;59:1030–6.
   PubMed Web of Science ®Google Scholar
• Curvers WL, ten Kate FJ, Krishnadath KK, Visser M, Elzer B, Baak LC, et al. Low-grade dysplasia in Barrett’s esophagus: overdiagnosed and underestimated. Am J Gastroenterol 2010;105:1523–30.
   PubMed Web of Science ®Google Scholar
• Rastogi A, Puli S, El-Serag HB, Bansal A, Wani S, Sharma P. Incidence of esophageal adenocarcinoma in patients with Barrett’s esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc 2008;67:394–8.
   PubMed Web of Science ®Google Scholar
• Abela JE, Going JJ, Mackenzie JF, McKernan M, O’Mahoney S, Stuart RC. Systematic four-quadrant biopsy detects Barrett’s dysplasia in more patients than nonsystematic biopsy. Am J Gastroenterol 2008;103:850–5.
   PubMed Web of Science ®Google Scholar
• Herszenyi L, Pregun I, Tulassay Z. Diagnosis and recognition of early esophageal neoplasia. Dig Dis 2009;27:24–30.
   PubMed Web of Science ®Google Scholar
• Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus. Am J Gastroenterol 2002;97:1888–95.
   PubMed Web of Science ®Google Scholar
• Wani S, Mathur SC, Curvers WL, Singh V, Herrero LA, Hall SB, et al. Greater interobserver agreement by endoscopic mucosal resection than biopsy samples in Barrett’s dysplasia. Clin Gastroenterol Hepatol 2010;8:783–8.
   PubMed Web of Science ®Google Scholar
• Montgomery E, Bronner MP, Goldblum JR, Greenson JK, Haber MM, Hart J, et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol 2001;32:368–78.
   PubMed Web of Science ®Google Scholar
• Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ; American Gastroenterological Association. American Gastroenterological Association technical review on the management of Barrett’s esophagus. Gastroenterology 2011;140:e18–52.
   PubMed Web of Science ®Google Scholar
• Edelstein ZR, Bronner MP, Rosen SN, Vaughan TL. Risk factors for Barrett’s esophagus among patients with gastroesophageal reflux disease: a community clinic-based case-control study. Am J Gastroenterol 2009;104:834–42.
   PubMed Web of Science ®Google Scholar
• Rubenstein JH, Taylor JB. Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux. Aliment Pharmacol Ther 2010;32:1222–7.
   PubMed Web of Science ®Google Scholar
• Souza RF, Huo X, Mittal V, Schuler CM, Carmack SW, Zhang HY, et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology 2009;137:1776–84.
   PubMed Web of Science ®Google Scholar
• Nason KS, Wichienkuer PP, Awais O, Schuchert MJ, Luketich JD, O’Rourke RW, et al. Gastroesophageal reflux disease symptom severity, proton pump inhibitor use, and esophageal carcinogenesis. Arch Surg 2011;146:851–8.
   PubMedGoogle Scholar
• Orlando RC. Pathophysiology of gastroesophageal reflux disease. J Clin Gastroenterol 2008;42:584–8.
   PubMed Web of Science ®Google Scholar
• Dvorak K, Dvorak B. Role of interleukin-6 in Barrett’s esophagus pathogenesis. World J Gastroenterol 2013;19:2307–12.
   PubMed Web of Science ®Google Scholar
• Fitzgerald RC, Abdalla S, Onwuegbusi BA, Sirieix P, Saeed IT, Burnham WR, et al. Inflammatory gradient in Barrett’s oesophagus: implications for disease complications. Gut 2002;51:316–22.
   PubMedGoogle Scholar
• Zampeli E, Karamanolis G, Morfopoulos G, Xirouchakis E, Kalampoki V, Bamias G, et al. Inflammatory infiltration of metaplastic epithelium and correlation to previous diagnosis of esophagitis and Barrett’s length. Scand J Gastroenterol 2012;47:900–6.
   PubMed Web of Science ®Google Scholar
• Fitzgerald RC, Onwuegbusi BA, Bajaj-Elliott M, Saeed IT, Burnham WR, Farthing MJ. Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut 2002;50:451–9.
   PubMed Web of Science ®Google Scholar
• O’Riordan JM, Abdel-latif MM, Ravi N, McNamara D, Byrne PJ, McDonald GS, et al. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Gastroenterol 2005;100:1257–64.
   PubMed Web of Science ®Google Scholar
• Poehlmann A, Kuester D, Malfertheiner P, Guenther T, Roessner A. Inflammation and Barrett’s carcinogenesis. Pathol Res Pract 2012;208:269–80.
   PubMed Web of Science ®Google Scholar
• Abdel-Latif MM, Duggan S, Reynolds JV, Kelleher D. Inflammation and esophageal carcinogenesis. Curr Opin Pharmacol 2009;9:396–404.
   PubMed Web of Science ®Google Scholar
• Quante M, Bhagat G, Abrams JA, Marache F, Good P, Lee MD, et al. Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell 2012;21:36–51.
   PubMed Web of Science ®Google Scholar
• Parks WC, Wilson CL, López-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004;4:617–29.
   PubMed Web of Science ®Google Scholar
• Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007;8:221–33.
   PubMed Web of Science ®Google Scholar
• Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2:161–74.
   PubMed Web of Science ®Google Scholar
• Mueller MM, Fusenig NE. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004;4:839–49.
   PubMed Web of Science ®Google Scholar
• Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006;25:9–34.
   PubMed Web of Science ®Google Scholar
• Salmela MT, Karjalainen-Lindsberg ML, Puolakkainen P, Saarialho-Kere U. Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett’s oesophageal adenocarcinoma. Br J Cancer 2001;85:383–92.
   PubMed Web of Science ®Google Scholar
• Herszenyi L, Hritz I, Pregun I, Sipos F, Juhasz M, Molnar B, et al. Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis. World J Gastroenterol 2007;13:676–82.
   PubMed Web of Science ®Google Scholar
• Harada H, Nakagawa H, Oyama K, Takaoka M, Andl CD, Jacobmeier B, et al. Telomerase induces immortalization of human esophageal keratinocytes without p16INK4a inactivation. Mol Cancer Res 2003;1:729–38.
   PubMed Web of Science ®Google Scholar
• Palanca-Wessels C, Klingelhutz A, Reid BJ, Norwood TN, Opheim KE, Paulson TG, et al. Extended lifespan of Barrett’s esophagus epithelium transduced with the human telomerase catalytic subunit: a useful in vitro model. Carcinogenesis 2003;24:1183–90.
   PubMed Web of Science ®Google Scholar
• Ryu JH, Lee A, Na JH, Lee S, Ahn HJ, Park JW, et al. Optimization of matrix metalloproteinase fluorogenic probes for osteoarthritis imaging. Amino Acids 2011;41:1113–22.
   PubMed Web of Science ®Google Scholar
• Li J, Chen K, Liu H, Cheng K, Yang M, Zhang J, et al. Activatable near-infrared fluorescent probe for In Vivo imaging of Fibroblast Activation Protein-alpha. Bioconjugate Chem 2012;23:1704–11.
   PubMed Web of Science ®Google Scholar
• Bird-Lieberman EL, Neves AA, Lao-Sirieix P, O’Donovan M, Novelli M, Lovat LB, et al. Molecular imaging using fluorescent lectins permits rapid endoscopic identification of dysplasia in Barrett’s esophagus. Nat Med 2012;18:315–21.
   PubMed Web of Science ®Google Scholar
• Dvorakova K, Payne CM, Ramsey L, Holubec H, Sampliner R, Dominguez J, et al. Increased expression and secretion of interleukin-6 in patients with Barrett’s esophagus. Clin Cancer Res 2004;10:2020–8.
   PubMed Web of Science ®Google Scholar
• Schönbeck U, Mach F, Libby P. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J Immunol 1998;161:3340–6.
   PubMed Web of Science ®Google Scholar
• Ito A, Mukaiyama A, Itoh Y, Nagase H, Thogersen IB, Enghild JJ, et al. Degradation of interleukin 1beta by matrix metalloproteinases. J Biol Chem 1996;271:14657–60.
   PubMed Web of Science ®Google Scholar
• Kaden JJ, Dempfle CE, Grobholz R, Tran HT, Kiliç R, Sarikoç A, et al. Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis. Atherosclerosis 2003;170:205–11.
   PubMed Web of Science ®Google Scholar
• Xu D, Sun Y, Bao G, Liu W, Zhu X, Cui S, et al. MMP-1 overexpression induced by IL-1β: possible mechanism for inflammation in degenerative lumbar facet joint. J Orthop Sci 2013;18:1012–19.
   PubMed Web of Science ®Google Scholar